75014-02-7

Upstream product

• 2020-90-8 2,4,5-Trimethoxyphenylacetone 
• 151-50-8 potassium cyanide 
• 134040-35-0 2,4,5-trimethoxy-β-methyl-β-nitrostyrene 

Downstream Products

• 75014-03-8 (RS)-3-(2,4,5-trimethoxyphenyl)-2-methylalanine 
• 75014-06-1 (S)-ethyl 2-amino-2-mwthyl-3-(2,4,5-trimethoxyphenyl)propanoate 
• 75014-08-3 (R)-ethyl 2-amino-2-mwthyl-3-(2,4,5-trimethoxyphenyl)propanoate 
• 75014-04-9 (RS)-ethyl 2-amino-2-methyl-3-(2,4,5-trimethoxyphenyl)propanoate 
• 72746-40-8 (S)-6-OH-α-Me-Dopa 
• 752934-50-2 (R)-6-OH-α-Me-Dopa 
• 65520-36-7 (RS)-3-(2,4,5-trihydroxyphenyl)-2-methylalanine 

Relevant academic research and scientific papers

Synthetic and preliminary hemodynamic and whole animal toxicity studies on (R, S)-, (R)-, and (S)-2-methyl-3-(2,4,5-trihydroxyphenyl)alanine

The synthesis, resolution, and absolute configuration assignment of 2-methyl-3-(2,4,5-trihydroxyphenyl)alanine (6-OH-α-Me-Dopa) are reported. Hemodynamic studies in the rat have shown that this structural analogue and potential metabolite of the clinicall